Xiaoyang Mou

621 citations
30 papers · 489 indexed · h-index 13
Topics
Bioinformatics and Genomic Networks (8 papers)Gene expression and cancer classification (7 papers)Alzheimer's disease research and treatments (5 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

Xiaoyang Mou

28 papers receiving 484 citations

Peers

Xiaoyang Mou
Comparison fields: 5 of 91
  • Molecular Biology 265
  • Biomaterials 106
  • Cancer Research 97
  • Physiology 74
  • Pulmonary and Respiratory Medicine 50
Replace Shan Liu with:
Shan Liu China
Emine Şalva Türkiye
Jianlin Jiao China
Xinxin Wang China
Kang Woo Lee South Korea
Yun Dong China
Anton Lennikov United States
Hyo Jung Shin South Korea
Jun Gi Rho South Korea
Mi‐Hyeon You South Korea
Xiaoyang Mou relative to Shan Liu China Shan Liu's profile →
Citations per field
00.5×1.5×1.8×
Shan Liu · 1×
Citations per year

Countries citing papers authored by Xiaoyang Mou

Since Specialization
Citations

This map shows the geographic impact of Xiaoyang Mou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Mou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Mou more than expected).

Fields of papers citing papers by Xiaoyang Mou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyang Mou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Mou. The network helps show where Xiaoyang Mou may publish in the future.

Co-authorship network of co-authors of Xiaoyang Mou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyang Mou. A scholar is included among the top collaborators of Xiaoyang Mou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyang Mou. Xiaoyang Mou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 2
4 29
5 17
6 11
7 8
8 18
9 11
10 37
11 12
12 12
13 19
14 15
15
Crude drugs as anticancer agents.
12
16 25
17 1
18 62
19 1
20 9

About Xiaoyang Mou

Xiaoyang Mou is a scholar working on Molecular Medicine, Biological Psychiatry and Cancer Research, having authored 30 papers that have together received 489 indexed citations. Recurring topics across this work include Bioinformatics and Genomic Networks (8 papers), Gene expression and cancer classification (7 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Biomaterials (106 citations), Cancer Research (97 citations) and Biological Psychiatry (11 citations). Xiaoyang Mou has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Wei Kong, Xiao Hu, Shuaiqun Wang, Dave Jao, Weiming Zeng, Jin Deng, Xudong Huang, Jack T. Rogers, Zhongxue Chen and Boyang Wei. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and IEEE Transactions on Biomedical Engineering.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026